Heterozygous OPA1 mutations in Behr syndrome
Author(s) -
Cécilia Marelli,
Patrizia AmatiBonneau,
Pascal Reynier,
Valérie Layet,
Antoine Layet,
Giovanni Stévanin,
E. Brissaud,
Dominique Bonneau,
A. Dürr,
Alexis Brice
Publication year - 2010
Publication title -
brain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.142
H-Index - 336
eISSN - 1460-2156
pISSN - 0006-8950
DOI - 10.1093/brain/awq306
Subject(s) - atrophy , ataxia , medicine , pathology , pediatrics , psychiatry
ARTICLESir, We read with interest the paper by Yu-Wai-Man et al. (2010) on patients with dominant optic atrophy-plus with OPA1 mutations, which follows on previous reports by the same group (Amati-Bonneau et al. , 2008; Hudson et al. , 2008), reporting the relatively high frequency (∼20%) and the large spectrum of extra-ocular neurological involvement in OPA1 disease.Here, we extend the clinical spectrum of OPA1 mutations to Behr syndrome, characterized by early-onset optic atrophy associated with pyramidal signs, ataxia and sometimes, posterior column sensory loss and mental retardation (Behr 1909; Thomas et al. , 1984). This clinical entity is probably a heterogeneous group of disorders, whose real causes are mostly unknown. In most cases, autosomal recessive inheritance has been suspected. A few patients with typical Behr syndrome and several with Costeff syndrome, a Behr syndrome-like disease associating optic atrophy with extrapyramidal signs, were shown to have type III 3-methylglutaconic aciduria (MGA type III), a recessive disease characterized …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom